12. Imaging Genetics and Addiction

  1. Bryon Adinoff3,4 and
  2. Elliot A. Stein5
  1. Vibhuti Srivastava1 and
  2. David Goldman2

Published Online: 2 NOV 2011

DOI: 10.1002/9781119998938.ch12

Neuroimaging in Addiction

Neuroimaging in Addiction

How to Cite

Srivastava, V. and Goldman, D. (2011) Imaging Genetics and Addiction, in Neuroimaging in Addiction (eds B. Adinoff and E. A. Stein), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119998938.ch12

Editor Information

  1. 3

    Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA

  2. 4

    VA North Texas Health Care System, Dallas, TX, USA

  3. 5

    National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA

Author Information

  1. 1

    Department of Molecular Pathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

  2. 2

    Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA

Publication History

  1. Published Online: 2 NOV 2011
  2. Published Print: 9 NOV 2011

ISBN Information

Print ISBN: 9780470660140

Online ISBN: 9781119998938



  • imaging genetics and addiction;
  • brain imaging;
  • intermediate phenotypes and genes;
  • imaging genetics, candidate gene focus;
  • single nucleotide polymorphisms (SNPs);
  • sensitivity to reward, motivation;
  • dopamine function modulation;
  • structural brain changes;
  • obstacles, addiction imaging genetics


This chapter contains sections titled:

  • Introduction

  • Domains of Vulnerability

  • Cognitive Function

  • Brain Morphometric Changes

  • Bridging Gaps

  • Imaging Pharmacogenetics

  • Conclusion

  • Glossary

  • References